Open Access
Volume 17, Numéro 4, Juillet-Août 2010
Dossier : Lipides marins
Page(s) 259 - 263
Section Prix de thèse
Publié en ligne 15 juillet 2010
  • Barker SA, Yap SP, Yuen KH, et al. An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14. J Control Release 2003; 91: 477–488. [CrossRef] [PubMed] [Google Scholar]
  • Bernback S, Blackberg L, Hernell O. Fatty acids generated by gastric lipase promote human milk triacylglycerol digestion by pancreatic colipase-dependent lipase. Biochim Biophys Acta 1989; 1001: 286–293. [CrossRef] [PubMed] [Google Scholar]
  • Bodmer MW, Angal S, Yarranton GT, et al. Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta 1987; 909: 237–244. [CrossRef] [PubMed] [Google Scholar]
  • Carriere F, Barrowman JA, Verger R, et al. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993; 105: 876–888. [CrossRef] [PubMed] [Google Scholar]
  • Carriere F, Moreau H, Gargouri Y, et al. Purification and biochemical characterization of dog gastric lipase. Eur J Biochem 1991; 202: 75–83. [CrossRef] [PubMed] [Google Scholar]
  • Carriere F, Renou C, Lopez V, et al. The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. Gastroenterology 2000; 119: 949–960. [CrossRef] [PubMed] [Google Scholar]
  • Charman SA, Charman WN, Rogge MC, et al. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res 1992; 9: 87–93. [CrossRef] [PubMed] [Google Scholar]
  • Charman WN, Porter CJ, Mithani S, et al. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86: 269–282. [CrossRef] [PubMed] [Google Scholar]
  • De Caro J, Sias B, Grandval P, et al. Characterization of pancreatic lipase-related protein 2 isolated from human pancreatic juice. Biochim Biophys Acta 2004; 1701: 89–99. [CrossRef] [PubMed] [Google Scholar]
  • Eaimtrakarn S, Rama Prasad YV, Ohno T, et al. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats. J Drug Target 2002; 10: 255–260. [CrossRef] [PubMed] [Google Scholar]
  • Eydoux C, De Caro J, Ferrato F, et al. Further biochemical characterization of human pancreatic lipase-related protein 2 expressed in yeast cells. J Lipid Res 2007; 48: 1539–1549. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez S, Chevrier S, Ritter N, et al. In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14. Pharm Res 2009; 26: 1901–1910. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez S, Jannin V, Rodier JD, et al. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim Biophys Acta 2007; 1771: 633–640. [CrossRef] [PubMed] [Google Scholar]
  • Fernandez S, Rodier JD, Ritter N, et al. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. Biochim Biophys Acta 2008; 1781: 367–375. [CrossRef] [PubMed] [Google Scholar]
  • Gargouri Y, Pieroni G, Rivière C, et al. Importance of human gastric lipase for intestinal lipolysis: an in vitro study. Biochim Biophys Acta 1986; 879: 419–423. [CrossRef] [PubMed] [Google Scholar]
  • Hauss DJ, Fogal SE, Ficorilli JV, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 1998; 87: 164–169. [CrossRef] [PubMed] [Google Scholar]
  • Holm R, Porter CJ, Edwards GA, et al. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Pharm Sci 2003; 20: 91–97. [CrossRef] [PubMed] [Google Scholar]
  • Hu Z, Tawa R, Konishi T, et al. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. Life Sci 2001; 69: 2899–2910. [CrossRef] [PubMed] [Google Scholar]
  • Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008; 60: 625–637. [CrossRef] [PubMed] [Google Scholar]
  • Rama Prasad YV, Eaimtrakarn S, Ishida M, et al. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Int J Pharm 2003; 268: 13–21. [CrossRef] [PubMed] [Google Scholar]
  • Rama Prasad YV, Minamimoto T, Yoshikawa Y, et al. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer. Int J Pharm 2004; 271: 225–232. [CrossRef] [PubMed] [Google Scholar]
  • Sek L, Porter CJ, Charman WN. Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. J Pharm Biomed Anal 2001; 25: 651–661. [CrossRef] [PubMed] [Google Scholar]
  • Sek L, Porter CJ, Kaukonen AM. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol 2002; 54: 29–41. [CrossRef] [PubMed] [Google Scholar]
  • Vaganay S, Joliff G, Bertaux O, et al. The complete cDNA sequence encoding dog gastric lipase. DNA seq 1998; 8: 257–262. [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.